Cite
HARVARD Citation
Toyama, T. et al. (2019). Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta‐analysis. Diabetes, obesity & metabolism. 21 (5), pp. 1237-1250. [Online].